Literature DB >> 18007151

Colloidal gold nanoparticles as a blood-pool contrast agent for X-ray computed tomography in mice.

Quan-Yu Cai1, Sun Hee Kim, Kyu Sil Choi, Soo Yeon Kim, Seung Jae Byun, Kyoung Woo Kim, Seong Hoon Park, Seon Kwan Juhng, Kwon-Ha Yoon.   

Abstract

OBJECTIVES: To present the pharmacokinetics and computed tomographic imaging efficacy of colloidal gold nanoparticles (AuNPs) as a blood-pool agent for x-ray computed tomography (CT). METHODS AND MATERIALS: To prepare the colloidal AuNPs, gold nanocrystals were modified using sulfhydrated polyethylene glycol (PEG). Cytotoxicity and histopathologic tests were carried out for toxicity evaluation. Six adult Balb/c mice underwent microcomputed tomography scans after injection of colloidal AuNPs (2.5 micromol Au/g body weight). Four mice with HT-1080 tumors were imaged for visualization of the tumor vasculature.
RESULTS: The PEG coated colloidal AuNPs appeared as spherical nanoparticles with 38-nm diameters. The AuNPs-PEG showed a biocompatibility without toxicity in the mice. We identified a stable imaging window for visualizing the vasculature system, immediately to 24 hours after injection. Microcomputed tomography imaging using AuNPs-PEG clearly visualized the tumor vascular structures.
CONCLUSION: Colloidal AuNPs show potential as a blood-pool agent for x-ray CT imaging.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18007151     DOI: 10.1097/RLI.0b013e31811ecdcd

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  78 in total

1.  Numerical evaluation of the effectiveness of colloidal gold as a contrast agent.

Authors:  Noritaka Yusa; Meiling Jiang; Kazue Mizuno; Mitsuru Uesaka
Journal:  Radiol Phys Technol       Date:  2008-11-19

Review 2.  Nanoparticles: a promising modality in the treatment of sarcomas.

Authors:  Michiro Susa; Lara Milane; Mansoor M Amiji; Francis J Hornicek; Zhenfeng Duan
Journal:  Pharm Res       Date:  2010-05-27       Impact factor: 4.200

Review 3.  Nanotechnology for computed tomography: a real potential recently disclosed.

Authors:  Nicolas Anton; Thierry F Vandamme
Journal:  Pharm Res       Date:  2013-07-30       Impact factor: 4.200

4.  Labeling monocytes with gold nanoparticles to track their recruitment in atherosclerosis with computed tomography.

Authors:  Peter Chhour; Pratap C Naha; Sean M O'Neill; Harold I Litt; Muredach P Reilly; Victor A Ferrari; David P Cormode
Journal:  Biomaterials       Date:  2016-02-09       Impact factor: 12.479

5.  Development of silica-encapsulated silver nanoparticles as contrast agents intended for dual-energy mammography.

Authors:  Roshan Karunamuni; Pratap C Naha; Kristen C Lau; Ajlan Al-Zaki; Anatoliy V Popov; Edward J Delikatny; Andrew Tsourkas; David P Cormode; Andrew D A Maidment
Journal:  Eur Radiol       Date:  2016-02-24       Impact factor: 5.315

6.  Evaluation of spectral photon counting computed tomography K-edge imaging for determination of gold nanoparticle biodistribution in vivo.

Authors:  Salim Si-Mohamed; David P Cormode; Daniel Bar-Ness; Monica Sigovan; Pratap C Naha; Jean-Baptiste Langlois; Lara Chalabreysse; Philippe Coulon; Ira Blevis; Ewald Roessl; Klaus Erhard; Loic Boussel; Philippe Douek
Journal:  Nanoscale       Date:  2017-11-30       Impact factor: 7.790

7.  Bismuth@US-tubes as a Potential Contrast Agent for X-ray Imaging Applications.

Authors:  Eladio J Rivera; Lesa A Tran; Mayra Hernández-Rivera; Diana Yoon; Antonios G Mikos; Irene A Rusakova; Benjamin Y Cheong; Maria da Graça Cabreira-Hansen; James T Willerson; Emerson C Perin; Lon J Wilson
Journal:  J Mater Chem B       Date:  2013-10-07       Impact factor: 6.331

8.  Engineering of hetero-functional gold nanorods for the in vivo molecular targeting of breast cancer cells.

Authors:  Mohammad Eghtedari; Anton V Liopo; John A Copland; Alexander A Oraevsky; Massoud Motamedi
Journal:  Nano Lett       Date:  2009-01       Impact factor: 11.189

9.  Dextran coated bismuth-iron oxide nanohybrid contrast agents for computed tomography and magnetic resonance imaging.

Authors:  Pratap C Naha; Ajlan Al Zaki; Elizabeth Hecht; Michael Chorny; Peter Chhour; Eric Blankemeyer; Douglas M Yates; Walter R T Witschey; Harold I Litt; Andrew Tsourkas; David P Cormode
Journal:  J Mater Chem B       Date:  2014-12-14       Impact factor: 6.331

10.  Theranostic gold nanoparticles modified for durable systemic circulation effectively and safely enhance the radiation therapy of human sarcoma cells and tumors.

Authors:  Daniel Y Joh; Gary D Kao; Surya Murty; Melissa Stangl; Lova Sun; Ajlan Al Zaki; Xiangsheng Xu; Stephen M Hahn; Andrew Tsourkas; Jay F Dorsey
Journal:  Transl Oncol       Date:  2013-12-01       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.